| A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults MN Oxman, MJ Levin, GR Johnson, KE Schmader, SE Straus, LD Gelb, ... New England Journal of Medicine 352 (22), 2271-2284, 2005 | 2992 | 2005 |
| Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication. JC Guatelli, KM Whitfield, DY Kwoh, KJ Barringer, DD Richman, ... Proceedings of the National Academy of Sciences 87 (5), 1874-1878, 1990 | 1305 | 1990 |
| The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein N Van Damme, D Goff, C Katsura, RL Jorgenson, R Mitchell, MC Johnson, ... Cell host & microbe 3 (4), 245-252, 2008 | 1279 | 2008 |
| Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene MY Chowers, CA Spina, TJ Kwoh, NJ Fitch, DD Richman, JC Guatelli Journal of virology 68 (5), 2906-2914, 1994 | 518 | 1994 |
| The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. CA Spina, TJ Kwoh, MY Chowers, JC Guatelli, DD Richman The Journal of experimental medicine 179 (1), 115-123, 1994 | 494 | 1994 |
| Vpu antagonizes BST-2–mediated restriction of HIV-1 release via β-TrCP and endo-lysosomal trafficking RS Mitchell, C Katsura, MA Skasko, K Fitzpatrick, D Lau, A Ruiz, ... PLoS pathogens 5 (5), e1000450, 2009 | 404 | 2009 |
| Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity HM Craig, MW Pandori, JC Guatelli Proceedings of the National Academy of Sciences 95 (19), 11229-11234, 1998 | 333 | 1998 |
| Long-term persistence of zoster vaccine efficacy VA Morrison, GR Johnson, KE Schmader, MJ Levin, JH Zhang, ... Clinical infectious diseases 60 (6), 900-909, 2015 | 325 | 2015 |
| Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy KE Schmader, MN Oxman, MJ Levin, G Johnson, JH Zhang, R Betts, ... Clinical infectious diseases 55 (10), 1320-1328, 2012 | 283 | 2012 |
| Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy HF Günthard, JK Wong, CC Ignacio, JC Guatelli, NL Riggs, DV Havlir, ... Journal of Virology 72 (3), 2422-2428, 1998 | 275 | 1998 |
| Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein MW Pandori, NJ Fitch, HM Craig, DD Richman, CA Spina, JC Guatelli Journal of virology 70 (7), 4283-4290, 1996 | 268 | 1996 |
| Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro CA Spina, JC Guatelli, DD Richman Journal of virology 69 (5), 2977-2988, 1995 | 246 | 1995 |
| BST-2/tetherin: a new component of the innate immune response to enveloped viruses DT Evans, R Serra-Moreno, RK Singh, JC Guatelli Trends in microbiology 18 (9), 388-396, 2010 | 243 | 2010 |
| Stimulation of NF-κB activity by the HIV restriction factor BST2 A Tokarev, M Suarez, W Kwan, K Fitzpatrick, R Singh, J Guatelli Journal of virology 87 (4), 2046-2057, 2013 | 218 | 2013 |
| HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment H Hauser, LA Lopez, SJ Yang, JE Oldenburg, CM Exline, JC Guatelli, ... Retrovirology 7, 1-16, 2010 | 200 | 2010 |
| Tetherin restricts productive HIV-1 cell-to-cell transmission N Casartelli, M Sourisseau, J Feldmann, F Guivel-Benhassine, A Mallet, ... PLoS pathogens 6 (6), e1000955, 2010 | 196 | 2010 |
| The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation MY Chowers, MW Pandori, CA Spina, DD Richman, JC Guatelli Virology 212 (2), 451-457, 1995 | 191 | 1995 |
| Mechanisms for the inhibition of HIV replication by interferons-α,-β, and-γ, in primary human macrophages PRA Meylan, JC Guatelli, JR Munis, DD Richman, RS Kornbluth Virology 193 (1), 138-148, 1993 | 184 | 1993 |
| Functional landscape of SARS-CoV-2 cellular restriction L Martin-Sancho, MK Lewinski, L Pache, CA Stoneham, X Yin, ME Becker, ... Molecular cell 81 (12), 2656-2668. e8, 2021 | 175 | 2021 |
| Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles K Fitzpatrick, M Skasko, TJ Deerinck, J Crum, MH Ellisman, J Guatelli PLoS pathogens 6 (3), e1000701, 2010 | 164 | 2010 |
